Company registration number:
09281686
4C Clinical Limited
Unaudited filleted financial statements
30 October 2025
4C Clinical Limited
Contents
Directors and other information
Accountants report
Statement of financial position and notes to the financial statements
4C Clinical Limited
Directors and other information
|
|
|
|
Directors |
Dr Samuel Trevor Maze |
|
|
Mrs Margaret Olive Maze |
|
|
|
|
|
|
|
Secretary |
Dr Samuel Trevor Maze |
|
|
|
|
|
|
|
Company number |
09281686 |
|
|
|
|
|
|
|
Registered office |
Bank Chambers |
|
|
Canterbury Road |
|
|
Lyminge |
|
|
Nr Folkestone |
|
|
Kent CT18 8HU |
|
|
|
|
|
|
|
Accountants |
Norman Brisk & Company Limited |
|
|
Bank Chambers |
|
|
Canterbury Road |
|
|
Lyminge Nr Folkestone |
|
|
Kent |
|
|
CT18 8HU |
|
|
|
4C Clinical Limited
Report to the board of directors on the preparation of the
unaudited statutory financial statements of 4C Clinical Limited
Year ended 30 October 2025
As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 30 October 2025 which comprise the statement of financial position and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Norman Brisk & Company Limited
Business Advisers and Taxation Consultants
Bank Chambers
Canterbury Road
Lyminge Nr Folkestone
Kent
CT18 8HU
22 July 2026
4C Clinical Limited
Statement of financial position
30 October 2025
|
|
|
2025 |
|
2024 |
|
|
|
|
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
512 |
|
683 |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
5,033 |
|
5,536 |
|
|
|
|
|
|
|
|
|
|
|
Creditors: amounts falling due within one year |
|
|
(
17,817) |
|
(
23,627) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Net current liabilities |
|
|
(
12,784) |
|
(
18,091) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Total assets less current liabilities |
|
|
(
12,272) |
|
(
17,408) |
|
|
|
|
|
|
|
|
|
|
|
Accruals and deferred income |
|
|
- |
|
(
1,954) |
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
_______ |
|
|
|
Net liabilities |
|
|
(
12,272) |
|
(
19,362) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
(
12,272) |
|
(
19,362) |
|
|
|
|
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
4C Clinical Limited
Year ended 30 October 2025
Notes to the financial statements
1.
Employee numbers
The average number of persons employed by the company during the year amounted to
2
(2024:
3
).
2.
Directors advances, credits and guarantees
|
During the year the directors entered into the following advances and credits with the company: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Amounts repaid |
Balance o/standing |
|
|
|
|
£ |
£ |
£ |
£ |
|
|
|
Dr Samuel Trevor Maze |
(
9,998) |
- |
9,998 |
- |
|
|
|
Mrs Margaret Olive Maze |
(
1,983) |
- |
1,983 |
- |
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
(
11,981) |
- |
11,981 |
- |
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
Balance brought forward |
Advances /(credits) to the directors |
Amounts repaid |
Balance o/standing |
|
|
|
|
£ |
£ |
£ |
£ |
|
|
|
Dr Samuel Trevor Maze |
(
3,560) |
(
6,438) |
- |
(
9,998) |
|
|
|
Mrs Margaret Olive Maze |
(
780) |
(
1,203) |
- |
(
1,983) |
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
(
4,340) |
(
7,641) |
- |
(
11,981) |
|
|
|
|
_______ |
_______ |
_______ |
_______ |
|
|
|
|
|
|
|
|
|
|
For the year ending 30 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
-
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
-
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
22 July 2026
, and are signed on behalf of the board by:
Dr Samuel Trevor Maze
Director
Company registration number:
09281686
The company is a private company limited by shares, registered in England.